Reports on a license given by the U.S. Food and Drug Authority to the Tysabri monoclonal antibody manufactured by Biogen Idec Inc. in 2004. Use of the drug in treating multiple sclerosis; Administration of the drug; Information on monoclonal antibodies; Function of Tysabri; Results of a clinical trial on Tysabri.
No Comments.